Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intellectual Disability | 6 | 2023 | 1045 | 0.890 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2025 | 78 | 0.880 |
Why?
|
| Frameshift Mutation | 1 | 2025 | 191 | 0.850 |
Why?
|
| Pain Management | 1 | 2024 | 195 | 0.750 |
Why?
|
| Chronic Pain | 1 | 2024 | 141 | 0.750 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2022 | 48 | 0.720 |
Why?
|
| Precision Medicine | 1 | 2024 | 344 | 0.700 |
Why?
|
| Phenotype | 11 | 2025 | 4304 | 0.700 |
Why?
|
| RNA-Binding Proteins | 1 | 2025 | 534 | 0.690 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 296 | 0.660 |
Why?
|
| Mutation | 8 | 2025 | 5926 | 0.620 |
Why?
|
| Collagen Type I | 1 | 2019 | 115 | 0.620 |
Why?
|
| Hearing Loss | 2 | 2019 | 199 | 0.570 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2019 | 167 | 0.540 |
Why?
|
| Microcephaly | 3 | 2025 | 343 | 0.530 |
Why?
|
| Collagen Type II | 1 | 2016 | 23 | 0.510 |
Why?
|
| Hip Joint | 1 | 2016 | 50 | 0.500 |
Why?
|
| Osteochondrodysplasias | 1 | 2016 | 66 | 0.490 |
Why?
|
| Genetic Association Studies | 2 | 2016 | 807 | 0.490 |
Why?
|
| Tibial Fractures | 1 | 2016 | 64 | 0.480 |
Why?
|
| Growth Disorders | 1 | 2016 | 184 | 0.460 |
Why?
|
| Developmental Disabilities | 2 | 2018 | 718 | 0.440 |
Why?
|
| Mitochondrial Diseases | 2 | 2025 | 145 | 0.390 |
Why?
|
| Haploinsufficiency | 3 | 2022 | 264 | 0.350 |
Why?
|
| Plasmapheresis | 1 | 2011 | 31 | 0.350 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2011 | 32 | 0.350 |
Why?
|
| Fibroblasts | 2 | 2025 | 820 | 0.330 |
Why?
|
| Pedigree | 5 | 2025 | 1655 | 0.330 |
Why?
|
| Transcription Factors | 3 | 2018 | 2341 | 0.330 |
Why?
|
| Peritoneal Dialysis | 1 | 2011 | 129 | 0.310 |
Why?
|
| Blood Transfusion | 1 | 2011 | 286 | 0.300 |
Why?
|
| DNA-Binding Proteins | 4 | 2020 | 1886 | 0.300 |
Why?
|
| Cardiomyopathies | 1 | 2011 | 493 | 0.250 |
Why?
|
| Genotype | 4 | 2022 | 2600 | 0.240 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2025 | 86 | 0.230 |
Why?
|
| CADASIL | 1 | 2024 | 7 | 0.220 |
Why?
|
| Glutarates | 1 | 2024 | 39 | 0.220 |
Why?
|
| Arginine-tRNA Ligase | 1 | 2024 | 6 | 0.210 |
Why?
|
| Ataxia | 1 | 2025 | 160 | 0.210 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2020 | 523 | 0.210 |
Why?
|
| Child, Preschool | 9 | 2025 | 14329 | 0.210 |
Why?
|
| Mutation, Missense | 3 | 2019 | 888 | 0.210 |
Why?
|
| Child | 10 | 2025 | 25060 | 0.210 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 2023 | 26 | 0.210 |
Why?
|
| Cell Transdifferentiation | 1 | 2024 | 59 | 0.200 |
Why?
|
| Acidosis, Lactic | 1 | 2023 | 29 | 0.200 |
Why?
|
| MELAS Syndrome | 1 | 2023 | 33 | 0.200 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2024 | 119 | 0.200 |
Why?
|
| Syndrome | 4 | 2020 | 1132 | 0.200 |
Why?
|
| Goldenhar Syndrome | 1 | 2023 | 15 | 0.200 |
Why?
|
| Movement Disorders | 1 | 2025 | 221 | 0.200 |
Why?
|
| Humans | 23 | 2025 | 126084 | 0.190 |
Why?
|
| Collagen Type V | 1 | 2022 | 3 | 0.190 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2022 | 34 | 0.180 |
Why?
|
| Male | 13 | 2025 | 62087 | 0.180 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 5 | 1 | 2021 | 4 | 0.170 |
Why?
|
| Metabolomics | 1 | 2024 | 455 | 0.170 |
Why?
|
| Micrognathism | 2 | 2018 | 65 | 0.170 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 417 | 0.170 |
Why?
|
| Hand Deformities, Congenital | 2 | 2018 | 95 | 0.170 |
Why?
|
| Collagen | 1 | 2022 | 293 | 0.170 |
Why?
|
| Brain Diseases | 1 | 2023 | 283 | 0.170 |
Why?
|
| Neck | 2 | 2018 | 141 | 0.170 |
Why?
|
| Female | 13 | 2025 | 67913 | 0.160 |
Why?
|
| Face | 2 | 2018 | 193 | 0.160 |
Why?
|
| SOXD Transcription Factors | 1 | 2019 | 4 | 0.160 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 447 | 0.150 |
Why?
|
| Drosophila melanogaster | 1 | 2025 | 816 | 0.150 |
Why?
|
| North America | 1 | 2019 | 250 | 0.150 |
Why?
|
| Histone Acetyltransferases | 1 | 2020 | 224 | 0.150 |
Why?
|
| Drosophila Proteins | 1 | 2025 | 756 | 0.150 |
Why?
|
| Genetic Variation | 1 | 2025 | 1520 | 0.150 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 1845 | 0.150 |
Why?
|
| Chromosome Deletion | 1 | 2021 | 642 | 0.140 |
Why?
|
| Exome | 3 | 2016 | 1064 | 0.130 |
Why?
|
| Animals | 6 | 2025 | 33119 | 0.130 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2016 | 14 | 0.130 |
Why?
|
| Galactosyltransferases | 1 | 2016 | 7 | 0.130 |
Why?
|
| Bone Diseases, Developmental | 1 | 2016 | 60 | 0.130 |
Why?
|
| Histones | 1 | 2020 | 505 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 576 | 0.120 |
Why?
|
| Adolescent | 5 | 2025 | 19935 | 0.120 |
Why?
|
| Autoantigens | 1 | 2016 | 104 | 0.120 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2016 | 111 | 0.120 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2021 | 422 | 0.120 |
Why?
|
| Behcet Syndrome | 1 | 2015 | 14 | 0.120 |
Why?
|
| Stroke | 1 | 2023 | 1005 | 0.120 |
Why?
|
| Eye Abnormalities | 1 | 2016 | 98 | 0.120 |
Why?
|
| Abnormalities, Multiple | 2 | 2018 | 964 | 0.120 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 266 | 0.120 |
Why?
|
| Amino Acid Substitution | 1 | 2016 | 397 | 0.120 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2015 | 48 | 0.120 |
Why?
|
| Infant | 5 | 2025 | 12761 | 0.110 |
Why?
|
| Alleles | 2 | 2016 | 1611 | 0.110 |
Why?
|
| Radiography | 1 | 2016 | 749 | 0.110 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2016 | 910 | 0.110 |
Why?
|
| Neurons | 1 | 2024 | 1919 | 0.110 |
Why?
|
| Mice | 4 | 2023 | 17584 | 0.090 |
Why?
|
| Muscle Hypotonia | 2 | 2024 | 187 | 0.090 |
Why?
|
| Heart Auscultation | 1 | 2011 | 4 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 4409 | 0.090 |
Why?
|
| Young Adult | 2 | 2019 | 9616 | 0.070 |
Why?
|
| Electrocardiography | 1 | 2011 | 918 | 0.060 |
Why?
|
| Adult | 3 | 2024 | 30253 | 0.060 |
Why?
|
| DNA Polymerase gamma | 1 | 2025 | 16 | 0.060 |
Why?
|
| Echocardiography | 1 | 2011 | 1097 | 0.060 |
Why?
|
| Leukemia, Megakaryoblastic, Acute | 1 | 2005 | 19 | 0.060 |
Why?
|
| Genes, Dominant | 1 | 2025 | 241 | 0.060 |
Why?
|
| Neoplasms | 1 | 2020 | 2848 | 0.060 |
Why?
|
| Disease Progression | 1 | 2011 | 2099 | 0.060 |
Why?
|
| Oncogene Proteins | 1 | 2005 | 133 | 0.060 |
Why?
|
| Receptor, Notch3 | 1 | 2024 | 11 | 0.060 |
Why?
|
| Centrioles | 1 | 2023 | 5 | 0.050 |
Why?
|
| Acute Kidney Injury | 1 | 2011 | 657 | 0.050 |
Why?
|
| Nitric Oxide Donors | 1 | 2023 | 19 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2025 | 239 | 0.050 |
Why?
|
| Facial Asymmetry | 1 | 2023 | 17 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2025 | 769 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2023 | 247 | 0.050 |
Why?
|
| Glutathione | 1 | 2023 | 195 | 0.050 |
Why?
|
| Citrulline | 1 | 2023 | 116 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 5050 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2005 | 674 | 0.050 |
Why?
|
| Ion Channels | 1 | 2023 | 200 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2023 | 585 | 0.040 |
Why?
|
| Arginine | 1 | 2023 | 335 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 363 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2024 | 393 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2024 | 8357 | 0.040 |
Why?
|
| Brain | 2 | 2023 | 3032 | 0.040 |
Why?
|
| Middle Aged | 1 | 2019 | 27329 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2023 | 676 | 0.040 |
Why?
|
| Acetylation | 1 | 2020 | 182 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2020 | 133 | 0.040 |
Why?
|
| Seizures | 1 | 2024 | 847 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2020 | 3256 | 0.040 |
Why?
|
| Multiprotein Complexes | 1 | 2020 | 191 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2025 | 2389 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 276 | 0.040 |
Why?
|
| Proteins | 1 | 2023 | 1015 | 0.040 |
Why?
|
| Language Development Disorders | 1 | 2019 | 177 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2020 | 780 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 349 | 0.030 |
Why?
|
| Transcriptome | 1 | 2024 | 1061 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 2875 | 0.030 |
Why?
|
| Histone Deacetylase 1 | 1 | 2016 | 20 | 0.030 |
Why?
|
| Corneal Opacity | 1 | 2016 | 20 | 0.030 |
Why?
|
| Megalencephaly | 1 | 2016 | 59 | 0.030 |
Why?
|
| Coloboma | 1 | 2016 | 41 | 0.030 |
Why?
|
| Facies | 1 | 2016 | 156 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1661 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 2544 | 0.030 |
Why?
|
| Genes, Recessive | 1 | 2016 | 185 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2016 | 229 | 0.030 |
Why?
|
| Cataract | 1 | 2016 | 143 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 2565 | 0.030 |
Why?
|
| Models, Biological | 1 | 2020 | 1370 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2016 | 554 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2020 | 3706 | 0.020 |
Why?
|
| Prognosis | 1 | 2021 | 4709 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 650 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2015 | 564 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 1205 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2190 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 2771 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 3680 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2024 | 16768 | 0.020 |
Why?
|
| T-Cell Acute Lymphocytic Leukemia Protein 1 | 1 | 2005 | 9 | 0.010 |
Why?
|
| GATA1 Transcription Factor | 1 | 2005 | 9 | 0.010 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 1 | 2005 | 5 | 0.010 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 2005 | 11 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2005 | 26 | 0.010 |
Why?
|
| Transcriptional Regulator ERG | 1 | 2005 | 39 | 0.010 |
Why?
|
| K562 Cells | 1 | 2005 | 95 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2005 | 685 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2005 | 323 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 588 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 1207 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2005 | 500 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 10394 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 2770 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 3599 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 12325 | 0.010 |
Why?
|